Terms: = Prostate cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
27 results:
1. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
2. Use of the prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary prostate Biopsies.
Schulze A; Christoph F; Sachs M; Schroeder J; Stephan C; Schostak M; Koenig F
Urol Int; 2020; 104(3-4):181-186. PubMed ID: 32224611
[TBL] [Abstract] [Full Text] [Related]
3. BAP18 is involved in upregulation of ccnd1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract] [Full Text] [Related]
4. Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
Vidal AC; Howard LE; De Hoedt A; Kane CJ; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Lechpammer S; Flanders SC; Freedland SJ
Cancer; 2019 Feb; 125(3):434-441. PubMed ID: 30427535
[TBL] [Abstract] [Full Text] [Related]
5. An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer.
Ayub SG; Kaul D; Ayub T
Gene; 2017 Oct; 631():1-9. PubMed ID: 28754634
[TBL] [Abstract] [Full Text] [Related]
6. Identification of microRNA signature and potential pathway targets in prostate cancer.
Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.
Gerke TA; Martin NE; Ding Z; Nuttall EJ; Stack EC; Giovannucci E; Lis RT; Stampfer MJ; Kantoff PW; Parmigiani G; Loda M; Mucci LA
Prostate; 2015 Dec; 75(16):1926-33. PubMed ID: 26469352
[TBL] [Abstract] [Full Text] [Related]
8. Trends in mortality after cancer diagnosis: A nationwide cohort study over 45 years of follow-up in Sweden by country of birth.
Abdoli G; Bottai M; Sidorchuk A; Moradi T
Cancer Epidemiol; 2015 Aug; 39(4):633-40. PubMed ID: 26153090
[TBL] [Abstract] [Full Text] [Related]
9. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
[TBL] [Abstract] [Full Text] [Related]
10. prostate atypia: does repeat biopsy detect clinically significant prostate cancer?
Dorin RP; Wiener S; Harris CD; Wagner JR
Prostate; 2015 May; 75(7):673-8. PubMed ID: 25597982
[TBL] [Abstract] [Full Text] [Related]
11. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
[TBL] [Abstract] [Full Text] [Related]
12. cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.
Dey D; Kenu E; Isenberg DA
Lupus; 2013 Aug; 22(9):919-27. PubMed ID: 23857987
[TBL] [Abstract] [Full Text] [Related]
13. Multiple primary malignant neoplasms: multi-center results from Turkey.
Babacan NA; Aksoy S; Cetin B; Ozdemir NY; Benekli M; Uyeturk U; Ali Kaplan M; Kos T; Karaca H; Oksuzoglu B; Zengin N; Buyukberber S
J BUON; 2012; 17(4):770-5. PubMed ID: 23335539
[TBL] [Abstract] [Full Text] [Related]
14. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract] [Full Text] [Related]
15. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract] [Full Text] [Related]
16. Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?
Mandal RK; Mittal RD
Urol Oncol; 2012 Sep; 30(5):555-61. PubMed ID: 20822933
[TBL] [Abstract] [Full Text] [Related]
17. Improved classifications of planar whole-body bone scans using a computer-assisted diagnosis system: a multicenter, multiple-reader, multiple-case study.
Sadik M; Suurkula M; Höglund P; Järund A; Edenbrandt L
J Nucl Med; 2009 Mar; 50(3):368-75. PubMed ID: 19223423
[TBL] [Abstract] [Full Text] [Related]
18. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
[TBL] [Abstract] [Full Text] [Related]
19. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
Cheung IY; Feng Y; Danis K; Shukla N; Meyers P; Ladanyi M; Cheung NK
Clin Cancer Res; 2007 Dec; 13(23):6978-83. PubMed ID: 18056173
[TBL] [Abstract] [Full Text] [Related]
20. cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract] [Full Text] [Related]
[Next]
